Puma Biotechnology Inc (PBYI) — Free Cash Flow Generation Index
Puma Biotechnology Inc (PBYI) has a Free Cash Flow Generation Index of 1.00x as of December 2025. Free cash flow of $14.46 Million represents 1% of operating cash flow ($14.42 Million). Explore how much does Puma Biotechnology Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Puma Biotechnology Inc Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for Puma Biotechnology Inc across 6 annual periods. For the full cash flow conversion analysis, see PBYI operating cash flow.
Annual Free Cash Flow Generation for Puma Biotechnology Inc (2019–2025)
Year-by-year Free Cash Flow Generation Index for Puma Biotechnology Inc. Check cash flow reinvestment rate of Puma Biotechnology Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $41.73 Million | $41.80 Million | $71.00K | ▼ 0.0% |
| 2024 | 1.00x | $38.86 Million | $38.92 Million | $56.00K | ▲ +87.7% |
| 2023 | 0.53x | $14.37 Million | $27.01 Million | $12.64 Million | ▼ -46.8% |
| 2021 | 1.00x | $20.65 Million | $20.65 Million | $1.00K | ▲ +104.2% |
| 2020 | -24.06x | $-19.25 Million | $800.00K | $20.05 Million | ▼ -2539.1% |
| 2019 | 0.99x | $22.07 Million | $22.38 Million | $306.00K | — |